APA

Baffert F., Régnier C. H., De Pover A., Pissot-Soldermann C., Tavares G. A., Blasco F., Brueggen J., Chène P., Drueckes P., Erdmann D., Furet P., Gerspacher M., Lang M., Ledieu D., Nolan L., Ruetz S., Trappe J., Vangrevelinghe E., Wartmann M., Wyder L., Hofmann F. & Radimerski T. (20101104). Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805. : Molecular cancer therapeutics.

Chicago

Baffert Fabienne, Régnier Catherine H, De Pover Alain, Pissot-Soldermann Carole, Tavares Gisele A, Blasco Francesca, Brueggen Josef, Chène Patrick, Drueckes Peter, Erdmann Dirk, Furet Pascal, Gerspacher Marc, Lang Marc, Ledieu David, Nolan Lynda, Ruetz Stephan, Trappe Joerg, Vangrevelinghe Eric, Wartmann Markus, Wyder Lorenza, Hofmann Francesco and Radimerski Thomas. 20101104. Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805. : Molecular cancer therapeutics.

Harvard

Baffert F., Régnier C. H., De Pover A., Pissot-Soldermann C., Tavares G. A., Blasco F., Brueggen J., Chène P., Drueckes P., Erdmann D., Furet P., Gerspacher M., Lang M., Ledieu D., Nolan L., Ruetz S., Trappe J., Vangrevelinghe E., Wartmann M., Wyder L., Hofmann F. and Radimerski T. (20101104). Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805. : Molecular cancer therapeutics.

MLA

Baffert Fabienne, Régnier Catherine H, De Pover Alain, Pissot-Soldermann Carole, Tavares Gisele A, Blasco Francesca, Brueggen Josef, Chène Patrick, Drueckes Peter, Erdmann Dirk, Furet Pascal, Gerspacher Marc, Lang Marc, Ledieu David, Nolan Lynda, Ruetz Stephan, Trappe Joerg, Vangrevelinghe Eric, Wartmann Markus, Wyder Lorenza, Hofmann Francesco and Radimerski Thomas. Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805. : Molecular cancer therapeutics. 20101104.